Relationship Between Bladder Distention and Hysteroscopy Application

Sponsor
Namik Kemal University (Other)
Overall Status
Completed
CT.gov ID
NCT01848847
Collaborator
(none)
102
1
2
3
34.1

Study Details

Study Description

Brief Summary

The purpose of the study is to investigate the advantages and disadvantages of bladder filling during hysteroscopy procedure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Hysteroscopy
N/A

Detailed Description

Women who should have diagnostic hysteroscopy procedure will be randomly allocated into two groups. In the first group hysteroscopy will be performed with a filled bladder and in the second group procedure will be performed with an empty bladder. The women will be assigned into groups randomly. The duration of the procedure, feasibility of the procedure and tolerability of procedure will be recorded.

Study Design

Study Type:
Interventional
Actual Enrollment :
102 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Diagnostic
Official Title:
The Impact of Bladder Distention on Execution of Diagnostic Hysteroscopy Procedure; a Randomised Controlled Trial.
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Jul 1, 2013
Actual Study Completion Date :
Jul 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Full Bladder

Hysteroscopy conducted under full bladder.

Procedure: Hysteroscopy

Experimental: Empty Bladder

Hysteroscopy conducted under empty bladder.

Procedure: Hysteroscopy

Outcome Measures

Primary Outcome Measures

  1. Ease of Cervical Entry [2 months]

    Ease of cervical entry which will be assessed by Likert scale.The outcome measures in this study were the ease of cervical entry (judged by the individual surgeons using a 5-point Likert scale: very difficult= 1, difficult= 2, fair = 3, easy= 4, and very easy = 5.

  2. Pain Scoring(VAS) [2 months]

    Pain scoring was made by 10 cm visual analog scale. pain score (recorded by the patient on a 10 -point visual analog scale (VAS) which means pain increases with increasing number

Secondary Outcome Measures

  1. Patient Acceptability and Pain Scoring [two months]

    Patient acceptability and pain scoring will be evaluated by Likert scale and visual analog scale.

  2. Procedure Duration [two months]

    Procedural time which will be measured in minutes

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women who are at reproductive age

  • Women who are not pregnant at the time of presentation

  • Women who are not nulliparous

Exclusion Criteria:
  • Women who have previous cervical surgery or cervical incompetence.

  • Women who have genitourinary infection

  • Women who have profuse uterine bleeding or recent uterine perforation

  • Women who have neurological disorders affecting evaluation of pain.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Namık Kemal University Faculty of Medicine Department of Obstetric and Gynecology Tekirdag Turkey 59100

Sponsors and Collaborators

  • Namik Kemal University

Investigators

  • Study Director: Cem Celik, Assist Prof, Namik Kemal University Faculty of Medicine Department of Obstetrics and Gynecology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
CEM CELIK, Assistant Professor, Namik Kemal University
ClinicalTrials.gov Identifier:
NCT01848847
Other Study ID Numbers:
  • 9598
First Posted:
May 8, 2013
Last Update Posted:
Dec 16, 2013
Last Verified:
Jul 1, 2013
Keywords provided by CEM CELIK, Assistant Professor, Namik Kemal University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Empty Bladder Full Bladder
Arm/Group Description Hysteroscopy conducted under empty bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Hysteroscopy conducted under full bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy
Period Title: Overall Study
STARTED 51 51
COMPLETED 49 48
NOT COMPLETED 2 3

Baseline Characteristics

Arm/Group Title Empty Bladder Full Bladder Total
Arm/Group Description Hysteroscopy conducted under empty bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Hysteroscopy conducted under full bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Total of all reporting groups
Overall Participants 49 48 97
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
49
100%
48
100%
97
100%
>=65 years
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
39.51
(7.04)
41.07
(7.68)
40.27
(7.36)
Sex: Female, Male (Count of Participants)
Female
49
100%
48
100%
97
100%
Male
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
Turkey
49
100%
48
100%
97
100%

Outcome Measures

1. Primary Outcome
Title Ease of Cervical Entry
Description Ease of cervical entry which will be assessed by Likert scale.The outcome measures in this study were the ease of cervical entry (judged by the individual surgeons using a 5-point Likert scale: very difficult= 1, difficult= 2, fair = 3, easy= 4, and very easy = 5.
Time Frame 2 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Empty Bladder Full Bladder
Arm/Group Description Hysteroscopy conducted under empty bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Hysteroscopy conducted under full bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy
Measure Participants 49 48
Mean (Standard Deviation) [units on a scale]
4.00
(0.86)
3.55
(0.90)
2. Secondary Outcome
Title Patient Acceptability and Pain Scoring
Description Patient acceptability and pain scoring will be evaluated by Likert scale and visual analog scale.
Time Frame two months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description
3. Secondary Outcome
Title Procedure Duration
Description Procedural time which will be measured in minutes
Time Frame two months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description
4. Primary Outcome
Title Pain Scoring(VAS)
Description Pain scoring was made by 10 cm visual analog scale. pain score (recorded by the patient on a 10 -point visual analog scale (VAS) which means pain increases with increasing number
Time Frame 2 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Empty Bladder Full Bladder
Arm/Group Description Hysteroscopy conducted under empty bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Hysteroscopy conducted under full bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy
Measure Participants 49 48
Mean (Standard Deviation) [units on a scale]
2.52
(1.2)
1.95
(1.1)

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Empty Bladder Full Bladder
Arm/Group Description Hysteroscopy conducted under empty bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy Hysteroscopy conducted under full bladder. Hysteroscopy : bladder filling before diagnostic outpatient hysteroscopy
All Cause Mortality
Empty Bladder Full Bladder
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Empty Bladder Full Bladder
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/49 (0%) 0/47 (0%)
Other (Not Including Serious) Adverse Events
Empty Bladder Full Bladder
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/49 (0%) 0/47 (0%)

Limitations/Caveats

difficulties in introduction of hysteroscopy

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title cem celik
Organization namik kemal university
Phone 905324205365
Email cemcel@yahoo.com
Responsible Party:
CEM CELIK, Assistant Professor, Namik Kemal University
ClinicalTrials.gov Identifier:
NCT01848847
Other Study ID Numbers:
  • 9598
First Posted:
May 8, 2013
Last Update Posted:
Dec 16, 2013
Last Verified:
Jul 1, 2013